F. Di Gennaro

Switching Patients with Non-Dialysis Chronic Kidney Disease from Oral Iron to Intravenous Ferric Carboxymaltose: Effects on Erythropoiesis-Stimulating Agent Requirements, Costs, Hemoglobin and Iron Status

J. Toblli, F. Di Gennaro, 2015, PloS one.

Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats.

J. Toblli, G. Cao, P. Forcada, 2004, American journal of hypertension.

Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.

P. Duarte, J. Toblli, F. Di Gennaro, 2007, Journal of the American College of Cardiology.

Understanding the Mechanisms of Proteinuria: Therapeutic Implications

J. Toblli, G. Cao, M. Angerosa, 2012, International journal of nephrology.

Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron.

J. Toblli, F. Di Gennaro, C. Rivas, 2015, Heart, lung & circulation.